3rd Quarter - Report — BOEHRINGER INGELHEIM USA CORPORATION, F… for BOEHRINGER INGELHEIM USA CORPORATION (2016)

Firm

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

Client

BOEHRINGER INGELHEIM USA CORPORATION

Income

—

Expenses

$610,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Cost Sharing (Preserving Access to Medicines).

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; 21st Century Cures. CMS Part B Centers for Medicare and Medicaid Innovation Demonstration (CMMI); CMS Rule Blended J Code for Biosimilars.

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Importation; Non-Interference; and Drug Pricing.

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Consumer Issues/Safety/Products CSP

Food and Drug Administration Safety & Innovation Act (FDASIA) [Implementation]; Prescription Drug User Fee Act VI; 21st Century Cures Proposal and Transparency.

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Animals ANI

Veterinary Biologics, S.1200 (Fairness to Pet Owners Act).

Lobbyist	Covered position, as disclosed
JONATHAN DORST	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1200 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.